tyrosyl-prolyl-leucyl-glycinamide has been researched along with arginine vasopressin in 1 studies
| Studies (tyrosyl-prolyl-leucyl-glycinamide) | Trials (tyrosyl-prolyl-leucyl-glycinamide) | Recent Studies (post-2010) (tyrosyl-prolyl-leucyl-glycinamide) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
|---|---|---|---|---|---|
| 109 | 0 | 0 | 12,278 | 422 | 1,212 |
| Protein | Taxonomy | tyrosyl-prolyl-leucyl-glycinamide (IC50) | arginine vasopressin (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lovejoy, DA; Rotzinger, S; Tan, LA | 1 |
1 review(s) available for tyrosyl-prolyl-leucyl-glycinamide and arginine vasopressin
| Article | Year |
|---|---|
Behavioral effects of neuropeptides in rodent models of depression and anxiety.
Topics: Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Cholecystokinin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Galanin; Humans; MSH Release-Inhibiting Hormone; Neuropeptide Y; Neuropeptides; Neuropsychological Tests; Oxytocin; Social Behavior; Urocortins | 2010 |